"Knowledge into action" - Exploration of an appropriate approach for constructing evidence-based clinical practice guidelines for hepatocellular carcinoma

BioScience Trends

Volumn 6, Issue 3, 2012, Pages 147-152

  Song, Peipei ^a   Gao, Jianjun ^a   Kokudo, Norihiro ^a   Dong, Jiahong ^b   Tang, Wei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Clinical practice guidelines (CPGs); Evaluation; Hepatocellular carcinoma (HCC); Standardized management of care

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY; ORGANIZATION; PRACTICE GUIDELINE; TRANSLATIONAL RESEARCH;

CARCINOMA, HEPATOCELLULAR; EVIDENCE-BASED MEDICINE; HUMANS; LIVER NEOPLASMS; ORGANIZATIONS; PRACTICE GUIDELINES AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84866777410     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2012.v6.3.147     Document Type: Article

References (20)

1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. BMJ. 1996; 312:71-72.
2. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: How to practice and teach EBM. 2nd ed, Churchill Livingstone, Edinburgh, UK, 2000.
3. Song P, Wu Q, Huang Y. Multidisciplinary team and team oncology medicine research and development in China. Biosci Trends. 2010; 4:151-160.
4. Song PP, Gao JJ, Kokudo N, Tang W. Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice. Drug Discov Ther. 2011; 5:261-265.
5. Gao JJ, Song PP, Tamura S, Hasegawa K, Sugawara Y, Kokudo N, Uchida K, Orii R, Qi FH, Dong JH, Tang W. Standardization of perioperative management on hepatobiliary-pancreatic surgery. Drug Discov Ther. 2012; 6:108-111.
6. Song PP, Gao JJ, Kokudo N, Tang W. New opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical application. Intractable Rare Dis Res. 2012; 1:95-97.
7. Pavlidis N. Evidence-based medicine: Development and implementation of guidelines in oncology. Eur J Cancer. 2009; 45 (Suppl 1):468-470.
8. Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010; 26:2183-2191.
9. Song P, Tobe RG, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W. The management of hepatocellular carcinoma around the world: A comparison of guidelines from 2001 to 2011. Liver Int. 2012; 32:1053-1063.
10. Group formed to establish "guidelines for evidencebased clinical practice for the treatment of liver cancer". Clinical practice guidelines for hepatocellular carcinoma. Kanehara, Tokyo, Japan, 2005. (in Japanese)
11. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010; 4:439-474.
12. Centre for Evidence Based Medicine. Oxford Centre for Evidence-based Medicine Levels of Evidence (March 2009). http://www.cebm.net/index.aspx?o=1025 (accessed 30 May 2012).
13. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, Koo WH; Asian Oncology Summit. Management of hepatocellular carcinoma in Asia: Consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009; 10:1111-1118.
14. Ferenci P, Fried M, Labrecque D, et al. World Gastroenterology Organization. Hepatocellular carcinoma (HCC): A global perspective. J Clin Gastroenterol. 2010; 44:239-245.
15. Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, Groot M, Sancho-Garnier H, Tsu VD; Global Summit Health Care Systems and Public Policy Panel. Breast cancer in limited-resource countries: Health care systems and public policy. Breast J. 2006; 12 (Suppl 1): S54-S69.
16. Kokudo N, Sasaki Y, Nakayama T, Makuuchi M. Dissemination of evidence-based clinical practiceguidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians. Gut. 2007; 56:1020-1021.
17. Sharma P, Saini SD, Kuhn LB, Rubenstein JH, Pardi DS, Marrero JA, Schoenfeld PS. Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci. 2011; 56:569-577.
18. Song P, Tang W, Tamura S, Hasegawa K, Sugawara Y, Dong J, Kokudo N. The management of hepatocellular carcinoma in Asia: A guideline combining quantitative and qualitative evaluation. Biosci Trends. 2010; 4:283-287.
19. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000; 32:1224-1229.
20. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology. 1999; 30:1434-1440.